Clinical Trials Directory

Trials / Conditions / Recurrent Esophageal Cancer

Recurrent Esophageal Cancer

14 registered clinical trials studyying Recurrent Esophageal Cancer.

StatusTrialSponsorPhase
TerminatedPaclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
NCT01249443
AIDS Malignancy ConsortiumPhase 1
CompletedPilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esop
NCT01612546
City of Hope Medical CenterPhase 2
TerminatedAkt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Meta
NCT01705340
National Cancer Institute (NCI)Phase 1
CompletedEverolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
NCT01231399
City of Hope Medical CenterPhase 1 / Phase 2
CompletedPralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have F
NCT01129206
Ohio State University Comprehensive Cancer CenterPhase 2
CompletedEuropean iNvestigation of SUrveillance After Resection for Esophageal Cancer
NCT03461341
St. James's Hospital, Ireland—
CompletedErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Nec
NCT00397384
National Cancer Institute (NCI)Phase 1
TerminatedFR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer
NCT00098527
National Cancer Institute (NCI)Phase 2
Completed3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastr
NCT00077545
National Cancer Institute (NCI)Phase 2
TerminatedA Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer
NCT00064259
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedErlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
NCT00045526
National Cancer Institute (NCI)Phase 2
Completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid
NCT00031681
National Cancer Institute (NCI)Phase 1
CompletedErlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
NCT00030498
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1